(Q45990464)

18 December 2017

title

[Effectiveness and safety of erlotinib in 2 patients with carcinoma of the cervix]. (English)

1 reference

18 December 2017

author name string

I Pérez Rodrigo

1

1 reference

18 December 2017

R Albornoz López

2

1 reference

18 December 2017

M Soto Rojas

3

1 reference

18 December 2017

I Fernández García

4

1 reference

18 December 2017

V Torres Degayón

5

1 reference

18 December 2017

language of work or name

1 reference

1 March 2009

1 reference

18 December 2017

Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria

published in

1 reference

18 December 2017

volume

33

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

96-99

1 reference

18 December 2017

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

Impact of the human papilloma vaccine on cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1130-6343%2809%2970994-8

7 January 2021

10.1016/S1130-6343(09)70994-8

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017